| Bioactivity | Tricarbonyldichlororuthenium(II) dimer is a pharmacological donor of CO releasing. CO releases from Tricarbonyldichlororuthenium(II) dimer prevents gastric mucosal oxidative damage induced by ischemia/reperfusion (I/R) improving gastric blood flow (GBF), decreasing DNA oxidation and inflammatory response on systemic level[1]. |
| Name | Tricarbonyldichlororuthenium(II) dimer |
| CAS | 22594-69-0 |
| Formula | C6Cl4O6Ru2 |
| Molar Mass | 512.01 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
| Reference | [1]. Magierowska K, et, al. Oxidative gastric mucosal damage induced by ischemia/reperfusion and the mechanisms of its prevention by carbon monoxide-releasing tricarbonyldichlororuthenium (II) dimer. Free Radic Biol Med. 2019 Dec; 145:198-208. |
Tricarbonyldichlororuthenium(II) dimer
CAS: 22594-69-0 F: C6Cl4O6Ru2 W: 512.01
Tricarbonyldichlororuthenium(II) dimer is a pharmacological donor of CO releasing. CO releases from Tricarbonyldichloror
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.